These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1716646)

  • 1. Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies.
    Hill WD; Lee VM; Hurtig HI; Murray JM; Trojanowski JQ
    J Comp Neurol; 1991 Jul; 309(1):150-60. PubMed ID: 1716646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies.
    Schmidt ML; Murray J; Lee VM; Hill WD; Wertkin A; Trojanowski JQ
    Am J Pathol; 1991 Jul; 139(1):53-65. PubMed ID: 1713021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal inclusions of Parkinson's disease.
    Gibb WR; Scott T; Lees AJ
    Mov Disord; 1991; 6(1):2-11. PubMed ID: 1848677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro assembly properties of mutant and chimeric intermediate filament proteins: insight into the function of sequences in the rod and end domains of IF.
    Gu L; Troncoso JC; Wade JB; Monteiro MJ
    Exp Cell Res; 2004 Aug; 298(1):249-61. PubMed ID: 15242779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.
    Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J
    Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identities, antigenic determinants, and topographic distributions of neurofilament proteins in the nervous systems of adult frogs and tadpoles of Xenopus laevis.
    Szaro BG; Gainer H
    J Comp Neurol; 1988 Jul; 273(3):344-58. PubMed ID: 2463277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque neurites and neuropil threads.
    Schmidt ML; Lee VM; Trojanowski JQ
    Lab Invest; 1991 Mar; 64(3):352-7. PubMed ID: 1706004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of CKII beta subunits in Lewy bodies of Parkinson's disease.
    Ryu MY; Kim DW; Arima K; Mouradian MM; Kim SU; Lee G
    J Neurol Sci; 2008 Mar; 266(1-2):9-12. PubMed ID: 17884098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to purified cortical Lewy bodies recognize the mid-size neurofilament subunit.
    Galvin JE; Lee VM; Baba M; Mann DM; Dickson DW; Yamaguchi H; Schmidt ML; Iwatsubo T; Trojanowski JQ
    Ann Neurol; 1997 Oct; 42(4):595-603. PubMed ID: 9382471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of epitopes shared by Hirano bodies and neurofilament proteins in normal and Alzheimer's disease hippocampus.
    Schmidt ML; Lee VM; Trojanowski JQ
    Lab Invest; 1989 Apr; 60(4):513-22. PubMed ID: 2468822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Lewy body in Parkinson's disease.
    Forno LS
    Adv Neurol; 1987; 45():35-43. PubMed ID: 3030070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies.
    Shepherd CE; McCann H; Thiel E; Halliday GM
    Neurobiol Dis; 2002 Mar; 9(2):249-57. PubMed ID: 11895376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some neural intermediate filaments contain both peripherin and the neurofilament proteins.
    Parysek LM; McReynolds MA; Goldman RD; Ley CA
    J Neurosci Res; 1991 Sep; 30(1):80-91. PubMed ID: 1795409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease.
    Iwatsubo T; Yamaguchi H; Fujimuro M; Yokosawa H; Ihara Y; Trojanowski JQ; Lee VM
    Am J Pathol; 1996 May; 148(5):1517-29. PubMed ID: 8623921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lewy bodies of Parkinson's disease. Immune electron microscopic demonstration of neurofilament antigens in constituent filaments.
    Pappolla MA
    Arch Pathol Lab Med; 1986 Dec; 110(12):1160-3. PubMed ID: 3022672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.